Improved overall and disease-specific survivalas well as decreased mortality risk of BC patients after chemotherapy and radiotherapy was observed in carriers of variant allelesof the XPC gene [65] and the XPD 751Gln allele combined with the XPC 939Gln allele [66]. Here, ERCC2 is linked to breast cancer.